Senior hands on every sample.
Scientists, clinicians and operators who chose to work on ctDNA at the edge of detection.
Pontus Rehn
Over 20 years in commercial leadership across the medical device and IVD industries, including VP Market Development, Chief Commercial Officer and Director of Commercial Strategy. Your first point of contact for partnerships.
Stefan Filges, PhD
Bioinformatician with a Ph.D. in ultra-sensitive sequencing, with Simsen since 2022. Co-author on the original SiMSen-Seq publication in Nature Protocols. He owns the science behind your results.
Jonna Eriksson, PhD
Ph.D. in genomics, bioinformatics, botany and evolution, with deep experience in quality management and regulatory policy. Former Assistant Professor at the University of Skövde and Senior R&D researcher at TATAA Biocenter. She keeps your data compliant.
The governance behind the science.
The board steering the company you would be partnering with, with the sector experience to back it.
Daniel Poté
Business developer at GU Ventures. Previously CEO of Predicare AB and Emotra AB, with other senior roles across medical technology and biotechnology.
Artur Aira
CEO of Active Health, with 25+ years across pharma, diagnostics and biotechnology. Previously CEO of Abigo Medical and SVP and BA manager at BICO, and a director on more than 30 company boards.
Tony Godfrey, PhD
Professor in the Department of Surgery and Computational Biomedicine at Boston University School of Medicine. Co-inventor of SiMSen-Seq and developer of further improvements, with past appointments at Rochester, Mount Sinai and Pittsburgh.
Jan Erik Smith
